Full-Time

Machine Learning Researchers

Generative AI, Open Level

Confirmed live in the last 24 hours

Flagship Pioneering

Flagship Pioneering

201-500 employees

Biotechnology firm creating health and sustainability solutions

No salary listed

Senior, Expert

Cambridge, MA, USA

Category
Applied Machine Learning
AI Research
AI & Machine Learning
Required Skills
LLM
Microsoft Azure
Python
Tensorflow
Pytorch
Machine Learning
AWS
Google Cloud Platform
Requirements
  • PhD in quantitative disciplines with contributions to research conferences or journals (e.g. NeurIPS, ICML, AAAI, ICLR)
  • Solid understanding of fundamental biology concepts and demonstrated ability to apply these to AI model development
  • Expertise in ML frameworks (PyTorch/TensorFlow/Jax) and robust experience in the Python data science ecosystem
  • Experience in training and deploying ML models on distributed computing services (g. AWS/GCP/Azure, or clusters)
Responsibilities
  • Designing and implementing generative models (e.g., LLMs, VAEs, diffusion models) tailored for biological sequences, structures, and molecular modalities
  • Integrating domain-specific constraints and priors into generative models to enhance biological plausibility and experimental viability
  • Developing rigorous testing, documentation, and model benchmarking
Desired Qualifications
  • Familiarity with state-of-the-art generative models for biological sequences, e.g., proteins, RNA, and DNA
  • Experience designing biological sequences or molecular structures with demonstrated improvements in real world outcomes (e.g. stability, binding affinity, or functional specificity)

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Size

201-500

Company Stage

N/A

Total Funding

$10.4B

Headquarters

Cambridge, Maryland

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Flagship's collaboration with Cambridge institutions accelerates biotech research and innovation.
  • AI-driven drug discovery complements Flagship's ventures in AI and biotechnology.
  • Flagship's focus on sustainability aligns with the growing importance of sustainable bioengineering.

What critics are saying

  • Increased competition from Trinity Capital may attract talent away from Flagship.
  • Strategic shifts at YourBio Health could impact Flagship's focus or resource allocation.
  • Dependency on Pfizer's expertise may limit Flagship's autonomy in decision-making.

What makes Flagship Pioneering unique

  • Flagship Pioneering systematically creates first-in-category companies in health and sustainability.
  • The company employs an evolutionary methodology to achieve transformational outcomes.
  • Flagship combines innovative capacity, leadership, and capital management in a single enterprise.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Flexible Work Hours

Company News

PR Newswire
Mar 10th, 2025
Flagship Pioneering Unveils Lila Sciences to Build Superintelligence in Science

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today unveiled Lila Sciences, a company building the world's first scientific...

ABL Advisor
Mar 3rd, 2025
Trinity Capital Expands Life Sciences Presence to East Coast, Appoints Orlando as Managing Director

Trinity Capital announced the appointment of John Orlando as Managing Director of Life Sciences, based in Boston.

Contract Pharma
Feb 19th, 2025
YourBio Health Taps Paul Owen as CEO

Paul Owen has been appointed as Chief Executive Officer of YourBio Health, a pioneer in remote blood collection technology, and CEO-Partner of Flagship Pioneering, a bioplatform innovation company.

PR Newswire
Jan 23rd, 2025
Flagship Pioneering, Cambridge University Health Partners, And Milner Therapeutics Institute Announce Collaboration To Accelerate Biotech Research And Innovation

First of its Kind Scientific Collaboration Will Engage Top Research Institutes in Cambridge, UK with Flagship PioneeringFocus on Scaling and Advancing Flagship's Breakthrough Science and Technologies through the Cambridge Life Sciences EcosystemLONDON, Jan. 23, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced an agreement with top life science organisations Cambridge University Health Partners (CUHP) and the Milner Therapeutics Institute (MTI) to collaborate to jointly advance breakthrough scientific research and technologies

Genetic Engineering & Biotechnology News
Jan 8th, 2025
Novo Nordisk, Valo Health Ink Expanded Up-to-$4.6B AI Collaboration

The following year, Flagship Pioneering formally announced the launch of privately-held Valo, joining with other undisclosed investors to bring the company's total financing to nearly $100 million.